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Abstract
Aggregatibacter actinomycetemcomitans is a gram-negative opportunistic oral pathogen. It is frequently associated
with subgingival biofilms of both chronic and aggressive periodontitis, and the diseased sites of the periodontium
exhibit increased levels of the proinflammatory mediator interleukin (IL)-1β. Some bacterial species can alter their
physiological properties as a result of sensing IL-1β. We have recently shown that this cytokine localizes to the
cytoplasm of A. actinomycetemcomitans in co-cultures with organotypic gingival mucosa. However, current
knowledge about the mechanism underlying bacterial IL-1β sensing is still limited. In this study, we characterized the
interaction of A. actinomycetemcomitans total membrane protein with IL-1β through electrophoretic mobility shift
assays. The interacting protein, which we have designated bacterial interleukin receptor I (BilRI), was identified
through mass spectrometry and was found to be Pasteurellaceae specific. Based on the results obtained using
protein function prediction tools, this protein localizes to the outer membrane and contains a typical lipoprotein signal
sequence. All six tested biofilm cultures of clinical A. actinomycetemcomitans strains expressed the protein according
to phage display-derived antibody detection. Moreover, proteinase K treatment of whole A. actinomycetemcomitans
cells eliminated BilRI forms that were outer membrane specific, as determined through immunoblotting. The protein
was overexpressed in Escherichia coli in both the outer membrane-associated form and a soluble cytoplasmic form.
When assessed using flow cytometry, the BilRI-overexpressing E. coli cells were observed to bind 2.5 times more
biotinylated-IL-1β than the control cells, as detected with avidin-FITC. Overexpression of BilRI did not cause binding
of a biotinylated negative control protein. In a microplate assay, soluble BilRI bound to IL-1β, but this binding was not
specific, as a control protein for IL-1β also interacted with BilRI. Our findings suggest that A. actinomycetemcomitans
expresses an IL-1β-binding surface-exposed lipoprotein that may be part of the bacterial IL-1β-sensing system.
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Introduction
Aggregatibacter actinomycetemcomitans is a Gram-negative
opportunistic human pathogen that causes chronic and
aggressive forms of periodontitis [1-3]. This pathogen is also
associated with systemic diseases, such as cardiovascular
diseases [4,5], and it possesses variety of virulence properties
(reviewed in 6), which enhances its resistance against human
defense mechanisms.
A. actinomycetemcomitans coaggregates with other oral
species [7,8] and forms robust biofilms [9,10], which may partly
explain the high tolerance of the species to host clearance
mechanisms and antibiotics [11,12]. Biofilm cells generally
show a different pattern of gene expression than their
planktonic counterparts. For example, an important periodontal
pathogen, Porphyromonas gingivalis, exhibits expression of
stress response genes following quorum-sensing events,
contributing to pathogen survival during infection [13,14]. In a
multispecies biofilm model, the presence of the periodontal
PLOS ONE | www.plosone.org 1 July 2013 | Volume 8 | Issue 7 | e70509
pathogens A. actinomyctemcomitans and P. gingivalis has
been shown to cause changes in the gene expression profiles
of the commensal strains in the biofilm [15]. A.
actinomycetemcomitans employs several specific strategies for
enhancing its survival in the host: it can secrete a leukotoxin
that directly targets human phagocyte cells, monocytes and
macrophages [16-18], while the other toxin produced by the
species, cytolethal-distending toxin, indirectly modulates
periodontal bone resorption [19] as well as periodontal
keratinocyte and fibroblast proliferation [20,21]. However, little
is known about the ability of the species to adjust its virulence
properties after sensing inflammation-related environmental
factors.
High levels of the human proinflammatory mediator
interleukin (IL)-1β are typical of periodontal inflammation sites
in tooth-supporting tissues [22]. IL-1β is a key inflammatory
mediator of the human innate immune system. This cytokine is
secreted primarily by human macrophages and monocytes
after sensing microbial danger signals. IL-1β stimulates its own
secretion [23], and the bursts of IL-1β that are released from
human cells are highly controlled (reviewed in 24). Human
mononuclear leukocytes detect A. actinomycetemcomitans as
a pathogen via NLRP3 inflammasome [25], which induces the
maturation of pro-IL-1β to its biologically active form.
Dysregulation of IL-1β activity can result in chronic diseases
such as periodontitis (reviewed in 24,26). In vitro, virulent
bacteria may sense the inflammatory levels of this signal by
binding it and altering their growth properties [27-29].
Furthermore, IL-1β is known to modulate virulence gene
expression in Staphylococcus aureus [30]. In previous studies,
we observed that A. actinomycetemcomitans biofilm
sequestered and then took up human IL-1β [31]. In addition, A.
actinomycetemcomitans increases the biofilm mass as a
physiological response to IL-1β [32], similar to the biofilms
formed by Gram-positive S. aureus [28,29]. As a secondary
response, IL-1β binding temporarily decreases the metabolic
activity of this species [32].
The findings of the studies described above strongly suggest
that bacteria may use IL-1β as an indicator of the host
inflammatory state. However, the mechanisms underlying the
uptake and subsequent regulatory pathway of IL-1β in bacteria
are not known. Currently, the only bacterial IL-1β-binding outer
membrane receptor has been characterized from the Gram-
negative bacterium Yersinia pestis [33]. Gram-negative
Pseudomonas aeruginosa has been shown to specifically
sense interferon (IFN)-γ via its outer membrane protein OprF
[34]. The interleukin receptor of Yersinia is known as capsule
antigen F1 assembly (Caf1A) protein. Caf1A is required for the
outer membrane localization of capsule antigen F1 protein,
which shows significant sequence similarity to a human IL-1α,
β receptor antagonist [35]. According to BLAST searches, the
A. actinomycetemcomitans genome does not show significant
sequence similarity with genes encoding Caf1A, Caf1 or the
human interleukin-1 receptor. Thus, we sought to specifically
study the mechanism of IL-1β transfer inside bacterial cells
using the oral pathogen A. actinomycetemcomitans as a model
species.
In this paper, we describe the interaction of human IL-1β with
a hypothetical lipoprotein extracted from A.
actinomycetemcomitans from a dissolved total membrane
protein fraction. Based on the observed interaction, we
designated this putative protein bacterial interleukin-1β
receptor I (BilRI). The interacting protein was identified via
mass spectrometry (MS) analysis, and its subcellular location
was analyzed using subcellular localization prediction tools for
bacterial proteins. The putative bacterial outer membrane IL-1β
receptor was overexpressed in an Escherichia coli strain
designed for membrane protein overexpression [36] and was
also produced in a soluble form in E. coli, without the typical
lipoprotein signal sequence. The E. coli cells containing BilRI in
their outer membrane showed an increased IL-1β-binding
capacity, and the soluble form of the protein interacted with
IL-1β in a microplate assay. Additionally, all of the tested
clinical A. actinomycetemcomitans strains expressed BilRI, and
the localization of the protein in the outer membrane was
verified through proteinase K treatment. Knowledge of bacterial
mechanisms for the binding and uptake of the central
inflammatory cytokine IL-1β is essential for understanding the
behavior and properties of the opportunistic pathogen under
inflammatory conditions.
Results
Identification of an IL-1β-binding membrane protein in
A. actinomycetemcomitans
The protein band that interacted with the anti-IL-1β antibody
was only visible in lanes containing either IL-1β or the IL-1β-
membrane protein (MP) combination (Figure 1A). The intensity
of this band was the same in both of these lanes (Figure 1A).
However, in a silver-stained gel, the band was much more
intense in the lane that contained both IL-1β and MP than in
the lane containing only IL-1β (Figure 1B). The band was
missing from the lane containing pure MP (Figure 1B). This
phenomenon was not observed when IL-1β was replaced with
the control protein soybean trypsin inhibitor (STI) (Figure 1C).
Thus, it was suggested that in the IL-1β-MP lane, the intense
band also contained proteins other than IL-1β and that those
proteins most likely interacted with IL-1β. The intense protein
band was extracted following non-denaturing-PAGE and
identified as putative uncharacterized protein G3ZCI1 of A.
actinomycetemcomitans D17P-3 through LC-MS/MS analysis.
The identified peptides covered 72% of the total protein
sequence (Figure 1D). In addition to A.
actinomycetemcomitans protein G3ZCI1, IL-1β was detected in
the band, confirming the potential interaction of the novel
protein with IL-1β. As the bacterial protein had no previously
known function, we designated it bacterial interleukin receptor I
(BilRI).
The amino acid sequence of BilRI was subjected to a BLAST
search against the genome sequence of A.
actinomycetemcomitans D7S, and an identical protein was
found. The BilRI sequence contained three almost identical
repeating sequences, which covered approximately 75% of the
mature protein sequence (Figure 2A). A similar protein was
found in several Pasteurellaceae species (Figures 2B and 3),
Novel IL-1b-Binding Bacterial Membrane Protein
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but not in E. coli. Its first 19 amino acids likely form the
lipoprotein signal sequence, which directs the protein to the
outer membrane in Gram-negative species (Figure 2B).
Recombinant BilRI localized to the outer membrane of
E. coli
When BilRI was expressed in E. coli with its native signal
sequence, the outer membrane protein fraction contained the
recombinant protein (Figure 4A), which was identified from a
silver-stained gel via LC-MS/MS. The purity of the outer
membrane protein fraction was confirmed through the detection
of heme proteins, which are only present in the inner
membrane fraction [37] (Figure 4B).
Overexpression of BilRI in the E. coli outer membrane
increased membrane frailty and caused self-
aggregation in the presence of calcium
The production of large amounts of recombinant BilRI in the
outer membrane of E. coli led to increased frailty of E. coli cells
(Figure 4C–E). When a bacterial pellet was frozen at -20°C and
resuspended in PBS, the suspension was more viscous when it
contained IPTG-induced cells than non-induced cells.
Additionally, after centrifugation, the pellet was looser (Figure
4C), and the supernatant contained a large amount of DNA
(Figure 4D), indicating that the outer membrane BilRI-
producing E. coli cells broke down during the freezing and
thawing cycle. However, 50% glycerol protected the cells from
breakdown (Figure 4E).
When the E. coli cells producing native BilRI were incubated
in the presence of 50 mM calcium, they began to aggregate.
This phenomenon was not observed in non-induced E. coli
cells (Figure 4F).
Recombinant BilRI increased the binding of IL-1β to E.
coli
The E. coli cells producing the recombinant full-length BilRI
protein bound as much IL-1β as the control cells in which BilRI
production was not induced based on estimation of the amount
of binding as the number of positively stained cells (Figure 5A).
However, when the mean fluorescence intensity was measured
in the positively stained cells, it was observed that the
recombinant BilRI-producing E. coli cells bound IL-1β more
efficiently per cell compared to the control cells (Figure 5B).
Neither the BilRI-producing E. coli cells nor the control cells
showed any significant binding of the control protein STI
(Figure 5A).
Figure 1.  The uncharacterized putative membrane protein from A. actinomycetemcomitans interacted with
IL-1β.  Membrane proteins (MP) were isolated from A. actinomycetemcomitans and dissolved in 4% CHAPS, after which they were
incubated with recombinant human IL-1β. The samples were subjected to native-PAGE and either blotted with anti-IL-1β (A) or
silver stained (B). Anti-IL-1β detected similar amounts of IL-1β in samples containing MP+IL-1β and a sample of pure IL-1β (A). In
the silver-stained gel, the equivalent band was more intense in the MP+IL-1β sample (B; red circle) than in the IL-1β sample,
indicating the presence of proteins other than IL-1β. This phenomenon was not observed in the control experiment using the
soybean trypsin inhibitor (STI) protein as a similar size control (C). The intense protein band (B; red circle) was cut out of the silver-
stained gel and identified as the putative uncharacterized G3ZCI1 protein from A. actinomycetemcomitans D17P-3 via LC-MS/MS
analysis. The identified peptides (D; bold red) covered 72% of the total protein sequence.
doi: 10.1371/journal.pone.0070509.g001
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The soluble recombinant form of BilRI bound IL-1β
The recombinant form of BilRI without the signal sequence,
expressed and purified from E. coli cytoplasm as a soluble
protein, was observed to bind IL-1β in a microplate assay
(Figure 5C). Moreover, the level of binding to IL-1β was greater
than to the blocking protein BSA (Figure 5C). However, no
significant difference was found between IL-1β binding and STI
binding (5C). Finally, IL-1β-coated wells bound the negative
control protein from A. actinomycetemcomitans (N-terminal
portion of RcpA) more weakly than BilRI (Figure 5C).
Different clinical isolates of A. actinomycetemcomitans
expressed BilRI in the outer membrane facing the
extracellular space
The mature BilRI protein traveled to an extracellular position
in A. actinomycetemcomitans D7S, as proteinase K treatment
of whole cells digested BilRI (Figure 6A). The outer membrane
protein fraction of strain D7S contained two forms of BilRI, with
sizes of approximately 35 kDa and 70 kDa (Figure 6A). The
larger of the two was also found in the inner membrane
preparate (Figure 6A). We hypothesized that the larger form
was a lipidated immature form of BilRI, as large amounts of the
smaller, 35 kDa form were only detected in the outer
membrane protein fraction (Figure 6A). However, both of these
Figure 2.  The bacterial IL-1β-binding protein consisted of a lipoprotein signal sequence and four repeated
sequences.  Sequence analysis using the SignalP 4.1 Server [54] revealed that the bacterial IL-1β-binding protein, which we
designated bacterial interleukin receptor I (BilRI), contained a putative signal sequence of 19 amino acids (A and B; bold red). The
sequence also contained 4 different 10-amino acid-long sequences (A and B; bold green, blue, purple and grey) repeated in the
same order three times. BLAST similarity searches [56] and Clustal W sequence alignment [57] revealed almost identical
sequences in other A. actinomycetemcomitans (Aa) strains and A. aphrophilus (A. aphr.) (B).
doi: 10.1371/journal.pone.0070509.g002
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Figure 3.  Only Pasteurellaceae species possessed proteins showing sequence similarity to BilRI.  BLAST similarity
searches [56] and Clustal W sequence alignment [57] only detected similar proteins in species belonging to the Pasteurellaceae
family. The proteins with the highest similarity were selected for further analysis. A bolded font indicates a similar amino acid to that
seen in BilRI. Different colors were used to distinguish the signal sequence (red) and the repeating sequences (green, blue, purple
and grey) from the other parts of the sequence (black).
doi: 10.1371/journal.pone.0070509.g003
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forms are likely surface exposed in the outer membrane, as
their respective bands could be eliminated by proteinase K
treatment (Figure 6A). These bands could also be detected by
another antibody clone, 16F7, in the same samples (Figure
6B). All four forms of BilRI (the proprotein, the unlipidated
mature form and the 70 kDa and 35 kDa forms) could be
detected in in vitro biofilm cultures of all of the tested clinical
isolates of A. actinomycetemcomitans, which were obtained
from periodontitis patients (Figure 6C).
Discussion
The purpose of this study was to identify an IL-1β-binding
receptor in the outer membrane of A. actinomycetemcomitans.
Various bacterial species are known to display specific
receptors for host cytokines [27,29,38], and two of such
receptors have been identified [33,34]. Although we were able
to demonstrate active binding and internalization of IL-1β in the
cells of our model bacterium (A. actinomycetemcomitans) and
to identify potential intracellular bacterial proteins that might
interact with IL-1β in earlier works [31,32], we have not
previously been able to identify the bacterial protein that
Figure 4.  Recombinant E. coli expressing BilRI in the outer membrane showed membrane frailty and self-
aggregation.  The A. actinomycetemcomitans bilRI gene, including the signal sequence, was cloned into E. coli. The production of
BilRI was induced using IPTG. The outer membrane fraction was isolated from both induced (IPTG+) and non-induced (IPTG-)
cells, and different dilutions of the membrane samples were subjected to SDS-PAGE, followed by silver staining (A). The purity of
the outer membrane (OM) fraction was confirmed by checking for the presence of inner membrane (IM) heme proteins using ECL
[59]. Only the IM preparate and positive control cytochrome c generated a signal indicating the presence of heme (B). When IPTG-
induced recombinant E. coli cells were frozen in the absence of protective agents, the cells began to break down, which was
observed in the form of a spongy bacterial pellet (C) and high levels of DNA released in the cell supernatant (D). The presence of
glycerol during freezing prevented the cells from breakdown, as they released less DNA during resuspension (E). When the IPTG-
induced E. coli cells were incubated in the presence of 50 mM CaCl2 at 37°C for 1 hour, they started to self-aggregate (F).
doi: 10.1371/journal.pone.0070509.g004
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interacts with IL-1β in the outer membrane of the bacterium.
Because IL-1β sensing likely leads to the formation of a robust
biofilm, discovering the outer membrane IL-1β receptor is
crucial for future studies addressing the role of this sensory
cascade in the virulence of this opportunistic pathogen.
We discovered that a previously uncharacterized outer
membrane lipoprotein of A. actinomycetemcomitans bound
IL-1β. Recombinant E. coli cells which overexpressed the
mature protein bound more efficiently IL-1β than the control
cells where the recombinant protein expression was not
induced. However, the finding that E. coli cells had intrinsic
ability to bind IL-1β was expected, since E. coli has been
shown to specifically bind IL-1β [27]. Although the purified
recombinant unlipidated form of the protein bound also the
control protein STI in ELISA assays, STI did not bind
significantly to the whole E. coli cells. This might be an
indication that a membrane environment is needed for the
protein to adapt to a form that binds specifically to IL-1β. The
IL-1β binding protein was designated bacterial interleukin
receptor I (BilRI) because this is the first identified bacterial IL-
Figure 5.  Recombinant BilRI bound IL-1β both in the outer membrane of E. coli and as soluble protein.  The IL-1β-binding
capacity of recombinant E. coli cells containing BilRI in the outer membrane was studied using the Fluorokine™ assay (R&D
Systems) and a flow cytometer. A similar number of the IPTG-induced cells bound IL-1β compared to non-induced cells (A). Neither
group of cells showed significant binding of the control soybean trypsin inhibitor (STI) protein (A). However, the IPTG-induced
recombinant E. coli cells bound IL-1β more efficiently than the non-induced cells, with the former showing a higher mean
fluorescence intensity per positively stained cell than latter (B). When BilRI was expressed in E. coli without its signal sequence and
purified from the cytoplasm, the obtained protein bound more efficiently to IL-1β than to BSA in a microplate assay (C). However,
BilRI bound to IL-1β as efficiently as to STI (C). The negative outer membrane control protein from A. actinomycetemcomitans (the
N-terminal portion of RcpA [32]) did not bind to IL-1β in the microplate assay (C). N=5 (A and B), and N=3-8 (C). Statistically
significant differences are indicated as follows: * p≤0.05, ** p<0.01, *** p<0.001 (Paired T-test).
doi: 10.1371/journal.pone.0070509.g005
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binding protein with no other known function than the binding of
IL-1β. The first bacterial IL-1β-binding protein to be described
was the Caf1A usher protein of Yersinia pestis [33], but its
main function is to take part to the production and construction
of the F1 capsule [39]. An outer membrane protein A (OmpA)
ortholog that senses IFN-γ and regulates virulence gene
expression through quorum-sensing signaling, OprF of
Pseudomonas aeruginosa [34], is also involved in the adhesion
of P. aeruginosa to various host cells [40,41]. The Caf1A usher
protein and OprF are both porin proteins [42,43] that form a
channel through the outer membrane of Gram-negative
bacteria. Bacterial lipoproteins linked to virulence traits can
possess various functions, ranging from potential antigen
activity to adhesion to host cells, and may play a role in
antibiotic resistance (reviewed in 44). Additionally, some
bacterial lipoproteins function as receptors or components of
more complex transport systems [44]. A recent study showed
that the conserved lipoprotein Lpp found in Gram-negative
species binds specifically to various cationic α-helical
antimicrobial peptides and participates in the internalization of
these antimicrobial peptides into the cytoplasm of the
bacterium [45]. This demonstrates that bacterial lipoproteins
may interact with components of the host innate defense
system. Whether BilRI binds only IL-1β, or could it also interact
with other host cytokines and chemokines, needs to be
confirmed in further studies.
The results of the present study suggest that BilRI is a
surface-exposed outer membrane lipoprotein that most likely
attaches to the lipid bilayer through its lipid portion. This
assumption is supported by the findings that most of the protein
Figure 6.  Surface-exposed BilRI was expressed in various clinical isolates of A. actinomycetemcomitans grown in
biofilms.  The surface exposure of BilRI in A. actinomycetemcomitans was examined via proteinase K treatment. During proteinase
K treatment, protein expression was inhibited with chloramphenicol, and the maturation of the proprotein was inhibited with
globomycin. Intact A. actinomycetemcomitans D7S cells were incubated with proteinase K for various time periods ranging from 0 to
24 hours, and the cells were then lysed via sonication. The samples were subsequently subjected to SDS-PAGE and
immunoblotted with an anti-BilRI antibody. Proteinase K treatment decreased the amount of both forms of BilRI (red quadrangles)
detected in outer membrane (OM) protein samples with two different antibody clones, 16B8 (A) and 16F7 (B), suggesting that BilRI
was surface exposed in A. actinomycetemcomitans. To examine BilRI expression in the clinical isolates, cell lysates were obtained
from young (21 hours) A. actinomycetemcomitans biofilm cultures through sonication. Samples containing approximately 0.3×107
disrupted cells were subjected to SDS-PAGE and immunoblotted using an anti-BilRI antibody (B). The letters in parenthesis
following the strain code indicate the serotypes (B).
doi: 10.1371/journal.pone.0070509.g006
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forms that were dominant in the outer membrane protein
fraction could be digested by proteinase K treatment of whole
A. actinomycetemcomitans cells and that the protein was highly
soluble when produced as a cytosolic form without the signal
sequence. The two forms that dominated the outer membrane
protein fraction were approximately 35 kDa and 70 kDa in size,
which is larger than both the predicted proprotein (19 kDa) and
mature unlipidated BilRI (17 kDa). The 70 kDa protein was also
present in the inner membrane protein fraction. Thus, we
hypothesized that the 35 kDa form corresponded to mature
lipidated BilRI, since it was only detected from the whole cells
and the outer membrane fraction and not from the inner
membrane faction. The level of the 19 kDa proprotein form
remained constant throughout proteinase K treatment, as
chloramphenicol inhibited protein synthesis, and globomycin
impeded the processing of the pro-form to the unlipidated
mature form. However, the lipidation and maturation process
needs to be studied in more detail to confirm the exact
composition of each protein form. It was unexpected to find that
the recombinant BilRI attached to the extracellular side of the
outer membrane in E. coli, as all of the lipoproteins previously
identified in E. coli travel to the periplasmic side [46]. In
summary, BilRI might be among the first proteins that interact
with IL-1β during one of the most complex pathways through
the cell wall of A. actinomycetemcomitans.
Sequence similarity searches revealed that protein
sequences similar to BilRI were mainly found in the
Pasteurellaceae family, including different strains of A.
actinomycetemcomitans and species such as Heamophilus
influenzae, Haemophilus parainfluenzae, Haemophilus
haemolyticus, Haemophilus somnus, Aggregatibacter
aphrophilus, Aggregatibacter segnis and Pasteurella multocida.
However, the function of the protein is unknown in majority of
these strains. The only known function among these
homologous proteins has been identified for Haemophilus
ducrey fibrinogen binder A (FgbA), which binds to human
fibrinogen and is an important virulence factor in humans [47].
However, we cannot claim that a similar protein cannot be
found in other bacterial families, as similar binding structures
can be formed from different amino acid sequences. Therefore,
it is important to also determine the three-dimensional structure
of BilRI to find similar receptors in other species.
Overexpression of BilRI in the outer membrane of E. coli
made the cells brittle and prone to lysis when they were frozen
without a supplementary protective agent, such as glycerol.
This finding was unexpected because we used an E. coli strain
that was specifically designed for the production of outer
membrane proteins. However, the vulnerability of the outer
membrane of Gram-negative bacteria may restrain the
recombinant production of outer membrane proteins containing
an appropriate signal sequence, which has complicated the
use of Gram-negative species as host strains in cell surface
display applications [48]. We attempted to overcome this
problem by shortening the IPTG induction time from three to
two hours, in addition to freezing the cells in the presence of
50% glycerol. Further research is needed to decipher how the
overexpression of BilRI affects the membrane integrity of A.
actinomycetemcomitans.
In conclusion, we identified a potential first-line binder and
receptor for the central human proinflammatory cytokine IL-1β
from the opportunistic periodontal pathogen A.
actinomycetemcomitans. The interest in this finding is
increased by the fact that no other functions have been
described for this protein or its homologs in other bacterial
species. Although specific binding of IL-1β by various Gram-
negative and Gram-positive bacterial species has been
reported [27,29,33], the identified BilRI protein could only be
found from the family Pasteurellaceae. Future studies
addressing the three-dimensional structure of the receptor will
resolve whether the protein structure is entirely novel, or if it
shared with other proteins present in different species. Since
human mononuclear leukocytes detect A.
actinomycetemcomitans as a pathogen leading to the
production of biologically active IL-1β [25], the findings reported
here present new opportunities for studying the role of IL-1β




Permission to collect and use clinical bacterial strains from A.
actinomycetemcomitans positive patients was obtained from
the Ethics committee of the Hospital District of Southwest
Finland, Turku, Finland. Subgingival microbial samples from
adult periodontitis patients were obtained with written informed
consent.
Identification of an IL-1β-binding membrane protein
The total membrane protein fraction was isolated from A.
actinomycetemcomitans D7S [49] using a previously described
protocol [50] with some modification. Briefly, plate-grown
(tryptic soy agar (TSA), 5% defibrinated sheep blood) A.
actinomycetemcomitans cells (8 plates/extraction) were
suspended in PBS1, pH 7.4 (10 mM Na2HPO4, 1.8 mM KH2PO4,
140 mM NaCl, 2.7 mM KCl), in a total volume of 30 ml. The
cells were then centrifuged (4,000×g, 20 min, 4°C) and
resuspended in 8 ml of PBS1-saccharose (PBS1, 150 mM
saccharose, 1 mM Pefablock SC [Roche Diagnostics,
Indianapolis, IN, USA]), disrupted via sonication (4×1 min on
ice, separated by 1 min cooling periods), and whole cells and
cell debris were removed via centrifugation (1 700×g, 20 min,
4°C). The supernatant was subsequently divided into two 6.5 ml
ultracentrifugation tubes (#355645, Beckman Instruments Inc.,
Palo Alto, CA, USA), and 500 µl of a 900 mM saccharose
solution in PBS1 was pipetted below the supernatant using a
capillary pipette. The tubes were then centrifuged (150,000×g,
2 hours 45 min, 4°C) to separate the membrane proteins from
the soluble ones. The membrane proteins were located in the
pellets, which were stored at -20°C for further use following
removal of the supernatant.
One membrane protein pellet was dispersed in 400 µl of
PBS1 containing 4% CHAPS (Sigma) and 1 mM
phenylmethylsulfonyl fluoride (PMSF; Sigma), first by careful
pipetting and then through slow rotation for 30 min at RT and
2.5 hours at 37°C. The remaining insoluble material was
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removed by spinning briefly in a minifuge. The protein content
in the supernatant was determined using the method described
by Lowry et al. [51]. Membrane proteins (total amount of 2 µg)
had been solubilized as described above were incubated with
300 ng of recombinant IL-1β (ReliaTech, GmbH,
Braunschweig, Germany) for 1 hour at RT, after which the
samples were run in a non-denaturing 4-15% Tris-HCl precast
gel (Criterion, Bio-Rad, USA) and transferred to nitrocellulose
membranes (Protran®Whatman®, Dassel, Germany) in an
Amersham Biosciences Semi-dry blotter. Two controls were
included in each gel, one of which contained only the
membrane proteins, while the other contained only IL-1β. The
membranes were blocked with 5% skimmed milk in PBS1
containing 0.05% Tween-20 (PBS1-T) at RT for 1 hour, washed
twice with PBS1-T at RT for 10 min and incubated with a rabbit
anti-IL-1β antibody (NB600-633; Novus 280 Biologicals,
Littleton, CO), diluted 1:4,000 in PBS1-T containing 0.5%
skimmed milk at 4°C overnight. Following incubation with the
primary antibody, the membrane was washed four times with
PBS1-T for 5 min each and incubated with IRDye® 800CW
Donkey Anti-Rabbit IgG (H+L) (#926-32213, LI-COR
Biosciences, Lincoln, NE, USA), diluted 1:10,000 in PBS1-T, at
RT for 1 hour. Prior to detection with Odyssey Infrared Imaging
System (LI-COR Biosciences), the membrane was washed six
times with PBS1-T for 5 min and then twice with PBS1 for 5 min.
Identical sample series were run and visualized using silver
staining [52].
A silver-stained protein band that reacted with IL-1β was cut
from a lane containing both MP and IL-1β. The protein sample
that was cut from the gel was in-gel digested with trypsin, and
the resultant peptides were analyzed with a nanoflow HPLC
system (EasyNano, Thermo, Fisher Scientific, Bremen,
Germany) coupled to an LTQ Orbitrap Velos Pro mass
spectrometer (Thermo, Fisher Scientific) equipped with a nano-
electrospray ionization source. The peptides were first loaded
onto a trapping column and were subsequently separated inline
on a 15 cm C18 column (75 µm × 15 cm, Magic 5 µm 200 Å
C18, Microm BioResources Inc., Sacramento, CA, USA). MS
data were acquired automatically using Thermo Xcalibur
software (Thermo, Fisher Scientific). An information-dependent
acquisition method was employed, which consisted of a TOF
MS survey scan with a mass range of 300-2,000 m/z. The ten
most intensive peaks were selected for fragmentation. The
obtained data files were searched for protein identification
using Proteome Discover (1.3) connected to in-house Mascot
(v 2.4) software against the UniProt database (release
2012_06). Only proteins with at least one “bold red” peptide
were included in further analyses, as “bold red” indicated a
peptide that was a best match for the assigned protein. Protein
hits against species other than A. actinomycetemcomitans or
humans were filtered out. Protein hits of less than two peptides
were also removed.
Bioinformatics
The SOSUI-GramN server [53] was employed to predict the
sub-cellular location of the protein. The sequence was
analyzed using the SignalP 4.1 Server [54] to predict the length
of the signal sequence and the LipoP 1.0 Server [55] to detect
the presence of the lipoprotein signal sequence. Sequence
similarity searches were performed with SIB using the BLAST
network service. The SIB BLAST network service employs a
server developed at SIB and NCBI BLAST 2 software [56].
Sequence alignments were performed using the Clustal W
(1.83) program of the SIB T-Coffee multiple sequence
alignment package [57].
Cloning and expression of the IL-1β-binding membrane
protein
The cloning of bilRI was performed as described for other
recombinant A. actinomycetemcomitans proteins [32], with
slight modifications. NdeI and XhoI restriction sites were
introduced into the forward and reverse primers, respectively,
and are underlined in the primers. The forward primer for bilRI
was 5’-ATACATATGAAAAAATCAGTATTAGCC-3’, and the
reverse primer was 5’-
ATACTCGAGTTATTTGCTTTCAGTTTC-3’ (Eurofins MWG
Operon, Ebersburg, Germany). The Phusion™ High-Fidelity
DNA polymerase (Finnzymes, Espoo, Finland) was used to
amplify the bilRI gene from A. actinomycetemcomitans D7S
DNA. An annealing temperature of 54°C was selected for the
amplification reaction. The obtained PCR products were
digested with NdeI and XhoI (Fermentas, Sankt Leon-Rot,
Germany) and cloned into the pET36b vector (Novagen,
Darmstadt, Germany) using T4 Ligase (Fermentas). The
plasmids were then transformed into E. coli TOP10 cells
(Invitrogen) via electroporation. Potential plasmid constructs
were sequenced in both directions using Eurofins MWG
Operon.
A plasmid construct that was verified to contain the correct
bilRI sequence was transformed into the E. coli C41(DE3) RIL
strain (Lucigen, Middleton, WI, USA), which was designed
specifically for the production of membrane proteins [36].
Various growth temperatures (room temperature [RT], 30°C,
37°C), isopropyl β-D-thiogalactoside (IPTG) concentrations
(0.1, 0.5, 1.0 mM) and induction times (3 hours, overnight)
were tested to find the optimal conditions for the production of
the outer membrane lipoprotein. Outer membrane proteins
were extracted from E. coli [58] and analyzed via SDS-PAGE
with silver staining [52]. The recombinant protein was identified
from a silver-stained gel via mass spectrometry, as described
above. Based on the results of these analyses, the expression
of BilRI was induced for 3 hours with 0.1 mM IPTG when cells
first reached an optical density of 0.6 at 600 nm in a special
medium (10 g/l tryptone, 24 g/l yeast extract, 2.5 g/l KCl, 2.5 g/l
NaCl, 0.6 g/l NaOH) containing 30 µg/ml kanamycin and
chloramphenicol at 37°C.
Determining the location of BilRI expressed in E. coli
The cellular fractions (cytosolic, inner membrane, outer
membrane) were extracted as described above and the
presence of recombinant BilRI was detected using silver
staining. The purity of the outer membrane fraction was
confirmed by the absence of inner membrane located heme
proteins [37]. The samples of different fractions, i.e. soluble
cytosolic, sarkocyl soluble inner membrane, and outer
membrane dissolved in 2% SDS, were dot blotted in
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nitrocellulose membrane and the heme proteins were detected
with ECL (Pierce®, Thermo Life science) [59].
Effect of overexpressed outer membrane BilRI on E.
coli membrane frailty and the self-aggregation of the
recombinant cells
Recombinant E. coli cells containing the complete BilRI
sequence were induced with IPTG as described above. Non-
induced cells were used as controls. The cells were harvested
(2000×g, 10 min, 4°C) and washed twice with PBS1. The cell
pellets were frozen to -20°C and then resuspended in PBS1.
Next, the cell suspensions were centrifuged (16,000×g, 15 min,
4°C), and 10 µl of the supernatant was run in a 0.8% agarose
gel containing the Midori Green DNA Stain (Nippon Genetics
Europe, Düren, Germany). To determine the optimal freezing
conditions for the recombinant E. coli cells, cell pellets were
suspended in different concentrations (20-50%) of glycerol
before freezing, and cell breakage was studied as described
above.
Recombinant E. coli cells that had been stored in 50%
glycerol were washed twice with HEPES buffer (10 mM
HEPES, pH 7.4) and suspended at an OD600nm=1 in HEPES
buffer supplemented with 50 mM CaCl2. E. coli cells in which
the production of BilRI was not induced were used as controls.
The cells were incubated in the CaCl2-supplemented buffer for
1 hour at 37°C, after which the self-aggregation of the cells was
estimated visually.
Determination of the IL-1β-binding capacity of E. coli
cells expressing BilRI
BilRI expression was induced in E. coli as described above,
except that the IPTG induction time was shortened to 2 hours.
Cells stored in 50% glycerol were washed three times with
PBS1 (5,900×g, 10 min, 4°C) prior to being fixed in PBS1
containing 1% formaldehyde, 1% BSA and 0.01% EDTA for 2
hours at 4°C. We applied the same fixation conditions which
were in a previous study, and were found to preserve the IL-1β-
binding capacity of A. actinomycetemcomitans [32]. The
number of cells in the E. coli samples was adjusted to 108
using the OD-specific cell concentration conversion, according
to which an OD600=1 for E. coli cells cultured in LB medium is
equal to 7.8±0.8x108 cell/ml [60]. Following the adjustment of
cell numbers, the cells were washed once with PBS1, collected
via centrifugation and resuspended in 1 ml of PBS1. For flow
cytometric assays, the reagents from a commercial
Fluorokine® kit (NFLB0, R&D Systems) were used for cell
staining. First, 2.5x106 cells in a final volume of 25 µl were
mixed with 10 µl of biotinylated IL-1β or 10 µl of the biotinylated
control protein STI prior to incubation at 4°C for 1 hour. Then,
10 µl of the avidin-FITC label, or 5 µl of Syto9 (LIVE/DEAD ®
BacLight™ Bacterial Viability and Counting Kit, L34856),
diluted 1:5 in sterile water, was added to the reaction mixture,
and incubation was continued at 4°C for 30 min. Finally, the
avidin-FITC-labeled samples were washed twice with 1x RDF1
buffer prior to resuspension of the cell pellets in 1 ml of the
buffer. The samples were analyzed with a Cell Lab Quanta SC
flow cytometer (Beckman Coulter, Inc.). During a flow
cytometric run, the bacterial cells were excited at 488 nm by an
argon ion laser. The green fluorescence of FITC-labeled avidin
binding biotinylated IL-1β on the cell surface or Syto9-stained
nucleic acids was detected through a 525 nm band pass filter.
The fluorescence signals were amplified in logarithmic mode.
Two parameters (the mean fluorescence intensity [MFI] and the
percentage of fluorescence-positive bacterial cells) were
determined separately from approximately 10,000 bacteria at a
flow rate of 200–300 events/s by gating the bacterial population
according to the green fluorescence/side scatter (SSC)
bivariate histogram. To exclude disturbing debris in the green
fluorescence/SSC histogram, the discriminant was set to the
SSC channel. Additionally, Syto9, which was the dye used for
staining nucleic acids in both live and dead bacteria, was used
to determine the actual proportion of bacteria in the sample.
Expression and purification of the cytosolic soluble
form of BilRI
According to the obtained amino acid sequence, BilRI was
predicted to contain a 19 amino acid-long signal sequence
typical of Gram-negative membrane lipoproteins. To produce
the soluble cytosolic form of the protein, the gene was cloned
without the signal sequence-coding region using the following
primers: forward, 5’-
ATTCATATGTGTGATGACAGCAAAACTTC-3’; reverse, 5’-
ATACTCGAGTTTGCTTTCAGTTTCGC-3’. The gene was then
cloned into the pET36b vector. However, during this
assessment, the recombinant protein did not contain the
translation stop codon, and the 8-histidine coding tag was
translated from the plasmid to the C-terminal end of the
recombinant protein. PCR amplification and plasmid
construction were performed as described above, and the
plasmids were electroporated into E. coli XL1 blue cells. The
potential plasmid constructs were sequenced in both directions
using the Eurofins MWG Operon.
The correct plasmid construct was transformed into BL21-
CodonPlus (DE3)-RIL cells (Stratagene, La Jolla, CA, USA).
The expression of cytosolic BilRI was induced for 3 hours with
0.1 mM IPTG when the cells reached an optical density at 600
nm of 1.3 in TB medium (12 g/l tryptone, 24 g/l yeast extract,
0.4% glycerol, 23.1 g/l KH2PO4 and 125.4 g/l K 2HPO4)
containing 30 µg/ml kanamycin and chloramphenicol at 37°C.
The cells (10 g) were harvested (5,000×g, 10 min, 4°C) and
dissolved in Buffer A (50 mM Na-phosphate, 800 mM NaCl, 20
mM imidazole, pH 7.5), to which a small amount of DNase I
(Roche Diagnostics, Mannheim, Germany) and 0.2 mM PMSF
were added. The cells were disrupted via sonication (4×15 s,
separated by 1 min of incubation on ice), and intact cells and
cell debris were collected via centrifugation (36,000×g, 30 min,
4°C). The supernatant, containing soluble BilRI, was applied to
a HisTrap™HP column (Amersham Biosciences), then washed
with 10% Buffer B (50 mM Na-phosphate, 800 mM NaCl, 0.5 M
imidazole, pH 7.5), and BilRI was eluted with 40% Buffer B.
Fractions that contained recombinant BilRI (eluted with 40%
and 100% Buffer B) were pooled and purified through size-
exclusion chromatography (Superdex 200 26/60 column; GE
Healthcare) and equilibrated with PBS2 (10 mM Na2HPO4, 145
mM NaCl, pH 7.2). Finally, the fractions containing BilRI were
pooled, concentrated and stored at −70°C prior to use.
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Interaction of the cytosolic soluble form of BilRI with
IL-1β
The IL-1β-binding capacity of purified recombinant BilRI was
examined using a microplate assay, similar to the method we
employed to study the interaction with the DNA-binding protein
HU [31], with slight modifications. A total of 100 ng of
recombinant IL-1β was bound to each well, and the applied
concentration of BilRI was 100 µg/ml. Bound recombinant BilRI
was detected with His-Probe™-HRP (Thermo Scientific) and
ABTS. As controls, similar amounts of STI (Sigma) and BSA
(Sigma) were immobilized. The recombinant N-terminal portion
of the outer membrane RcpA protein of A.
actinomycetemcomitans [32] was used as a negative control
protein that did not show significant binding to IL-1β.
Selection and screening of BilRI-recognizing antibody
fragments
The synthetic single-chain antibody fragment (scFv) phage
libraries ScFvM and ScFvP were cloned into the pEB32x
phagemid. The methods used for M13 phage display, the
cloning of the scFvs into the screening vector and the
expression of scFv-AP (AP = bacterial alkaline phosphatase)
fusion proteins were described by Huovinen et al. [61]. The
ScFvP library was originally reported by Brockmann et al. [62].
Briefly, purified recombinant soluble BilRI was immobilized on
Dynabeads® M-270 Epoxy (Life Technologies Inc.) using 0.3
mg of antigen per mg of beads, according to the instructions of
the Dynabeads® Antibody Coupling Kit. The two antibody
phage libraries were mixed in a 1:1 ratio for selection. The total
phage input was 5x1012 colony-forming units in the first round
and 5x1010 in the second round. The mass of antigen-coupled
beads used in the selections was 1 mg or 0.1 mg, respectively.
The phage were incubated with the beads in TBS1 (50 mM
Tris-HCl, 150 mM NaCl, pH 7.5) containing 0.05% Tween-20
and either 1% milk (1st round) or 1% BSA (2nd round) for 1 hour
at RT with rotation. The unbound phage were removed by
washing two (1st round) or three times (2nd round) with the
buffer used during binding, followed by one wash with TBS1 +
0.05% Tween-20 and one wash with TBS1. Elution of the
bound phage was performed with trypsin.
For single-clone immunoactivity screening, scFvs were
cloned from the phagemid (second-round output) into the
pLK06H vector using the SfiI restriction enzyme and expressed
as scFv-AP fusion proteins in XL1-Blue (Stratagene) in a 96-
well format. To test the activity of antibody fragments in
sandwich immunoassays, BilRI was immobilized on Maxisorb
plates (Nunc A/S, Thermo Fisher Scientific) (100 ng/100 µl/well
in PBS3, pH 7.4 [10 mM Na2HPO4, 2 mM KH2PO4, 37 mM
NaCl, 2.7 mM KCl]) through incubation at 4°C, overnight. After
removing the unbound antigen, the wells were blocked with
TBS1 + 1% milk for 2 hours, followed by the addition of the
scFv-AP sample (bacterial cell lysate). pNPP (1 mg/ml 4-
nitrophenyl phosphate disodium salt hexahydrate [Sigma-
Aldrich, UK] in 500 mM Tris-HCl, 200 mM NaCl, 10 mM MgCl2,
pH 9.0) was used as a substrate for detection. Color
development was measured with a Victor Multilabel counter
(PerkinElmer/Wallac, Finland) at 405 nm. Ten active clones
were identified and produced in 50 ml volumes, then extracted
from the cells using the freeze-thaw method. A lysate was
employed in the experiments after removing cell debris via
centrifugation. The capability of the active clones to bind BilRI
was verified through western blotting, and clone 16B8 was
selected for use in further analyses.
Expression of BilRI in various clinical isolates of A.
actinomycetemcomitans
Clinical isolates of A. actinomycetemcomitans were collected
from periodontitis patients. Subgingival microbial samples from
adult periodontitis patients were obtained, with written informed
consent, at the Community Dental Health Care Center of Turku
(Institute of Dentistry, University of Turku) by students or
dentists as part of periodontal examinations and treatment. The
samples were collected at baseline or at the treatment
evaluation appointment, if disease still existed. A.
actinomycetemcomitans was detected in the samples via either
PCR or culturing. Both chronic and aggressive periodontitis
patients were included in the study. Patients were excluded if
they had been treated with antibiotics during the past three
months, were pregnant, had severe health problems or were
on immunosuppressive medications. Patient smoking was
recorded. A. actinomycetemcomitans strains were cultured at
the Helsinki University Hospital Laboratory (HUSLAB, Helsinki,
Finland), and the strains were further PCR serotyped [63,64] at
the Department of Biochemistry and Food Chemistry,
University of Turku. Additionally, three clinical strains, D7S
(serotype a), SA1398 (serotype b) and SA1151 (serotype c),
were used, which have shown IL-1β-binding capacity in our
earlier studies [32]. Biofilm cultures were generated as we
described for previous IL-1β binding assays [32]. Briefly,
biofilms were cultured in cell culture bottles using a total culture
volume of 5 ml and an inoculum of 5×108 cells. The biofilms
were first cultured in TSB medium supplemented with 0.6%
yeast extract and 0.8% glucose in a candle jar at 37°C for
approximately 18 hours, after which they were washed twice
with 10 ml of PBS1. Biofilm growth was continued in
RPMI-1640 medium supplemented with 4.1 mM glutamine
(Sigma) for another 3 hours, prior to the collection of the biofilm
cells in 1 ml of PBS1 with a cell scraper. The cells were
suspended in Laemmli SDS-PAGE sample buffer at a final
concentration of 450 mg/ml, corresponding to approximately
9×109 CFU/ml. Then, the cells were disrupted through
sonication on ice (8-12 microns, 4x1 min, one minute break
between each sonication), samples were boiled for 5 min, and
aliquots containing 0.3×107 disrupted cells were run in
10.5-14% Tris-HCl precast gels (Criterion, Bio-Rad), after
which they were transferred to nitrocellulose membranes in an
Amersham Biosciences Semi-dry blotter. The membranes were
blocked with 2.5% BSA in TBS2-T (25 mM Tris, 0.15 M NaCl,
0.05% Tween-20, pH 7.6) at 4°C overnight, followed by
washing twice with TBS2-T for 5 min. The membrane was then
incubated with the alkaline phosphatase-fused recombinant
anti-BilRI antibody clone 16B8, diluted to 1:500 in 0.5% BSA in
TBS2-T, at RT for 2 hours and washed again twice as
described above. The bound anti-BilRI antibody was detected
using a 1:1,000 dilution (in 0.5% BSA supplemented TBS2-T) of
a biotinylated anti-alkaline phosphatase antibody (NB600-500;
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Novus Biologicals, Cambridge, UK) at RT for 2 hours, after
which the secondary antibody was detected with HRP-labeled
streptavidin (S2438, Sigma), diluted to 250 ng/ml in 0.5% BSA
in PBS1-T, at RT for 2 hours. Finally, the membrane was
washed with PBS1-T and detected using the ECL substrate
(Pierce®, Thermo Scientific) and Biomax Light film (Kodak,
Rochester, NY, USA).
Proteinase K treatment to examine the surface
exposure of BilRI in A. actinomycetemcomitans
To examine the surface exposure of BilRI in A.
actinomycetemcomitans cells, a slightly modified version of a
previously published proteinase K treatment protocol [65] was
employed. A. actinomycetemcomitans D7S cells that had been
cultured for 3 days on TSA plates were suspended in PBS1 and
collected via centrifugation at 3,800×g. The pellets were
resuspended in PBS1, and the suspensions were filtered
through a 100 mm Nylon Cell Strainer (BD FalconTM #2360).
The cell density was adjusted with Proteinase K buffer (50 mM
Tris-HCl pH 7.5, 5 mM CaCl2, 40 µg/ml chloramphenicol)
supplemented with 55 µg/ml globomycin (G1424, Sigma) to
1.7x108 cells/ml. Chloramphenicol was used to hamper protein
synthesis, and globomycin was used to inhibit SPII function
[66]. Pre-treatment was performed by shaking at 37°C for 30
minutes. Then, proteinase K was added to 4.5x107 treated
bacteria to a final concentration of 2 mg/ml. In the control
samples, proteinase K was replaced with sterile water. The
proteolysis reactions were performed through rotation at 37°C
for 5 hours or 21 hours, before the reactions were stopped by
the addition of PMSF at a 1 mM final concentration. The cells
were then collected and washed with proteinase K buffer
supplemented with 1 mM PMSF. Finally, the pellets were
suspended in Laemmli buffer and lysed via sonication. To
remove intact cells, the samples were centrifuged at 1,100×g
for 20 minutes. The soluble fraction was boiled prior to loading
the samples into 10.5-14% Precast Tris-HCl Gels (Criterion,
Bio-Rad). Additionally, the inner and outer membrane fractions
of A. actinomycetemcomitans were extracted as described by
Paul-Satyaseela et al. [50] and were used as control samples.
The proteins in the gels were electroblotted onto
nitrocellulose membranes. When the proteolysis of BilRI was
investigated, the membrane was blocked with 3% BSA in
TBS2-T at 4°C overnight. All remaining steps were performed at
RT. First, the membrane was washed twice with TBS2-T prior
to a 2 hour incubation with a 1:500 dilution of an anti-BilRI
alkaline phosphatase-conjugated antibody in TBS2-T
supplemented with 0.5% BSA (BSA/TBS2-T). The primary
antibody was custom made through the M13 phage display
procedure, as described above. The membrane was
subsequently washed twice with TBS2-T and incubated with a
1:1,000 dilution of a polyclonal bacterial anti-alkaline
phosphatase antibody conjugated to biotin (NB600-500, Novus
biologicals) in BSA/TBS2-T for 2 hours. Following washing, the
membrane was incubated with 250 ng/ml HRP-labeled
streptavidin (S2438, Sigma) in BSA/TBS2-T for 1 hour and
washed several times with TBS2-T prior to the addition of the
ECL Western blotting substrate (Pierce®, Thermo Scientific).
Biomax Light film (Kodak) was used in the detection step. The
outer membrane protein RcpA was used as a positive control in
proteolysis analysis and was immunostained accordingly. The
membrane was blocked with 5% skimmed milk in PBS1
supplemented with 0.05% Tween-20 (PBS1-T) at RT for 1 hour.
After washing twice with PBS1-T the membrane was incubated
with a rabbit polyclonal anti-RcpA antibody (0.8 µg/ml; Abcell,
Tampere) in PBS1-T containing 0.5% skimmed milk at 4°C
overnight. The next day, the membrane was incubated with an
ECL™Rabbit IgG, HRP-linked whole Ab (5.8 ng/ml; NA934, GE
Healthcare) at RT for 2 hours, after which detection was carried
out described for the BilRI experiments.
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